$SMID Balance Sheet | Understand Stock

$SMID

$21.20 -$0.09 (0.4%) Close

$SMID Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Current assets
Cash
Investment securities, available-for-sale, at fair value

Cash
Accounts receivable, net
Trade - billed (less allowances of approximately $871 and $539, respectively), including contract retentions
Trade - unbilled
Inventories, net
Raw materials
Finished goods
Prepaid expenses
Refundable income taxes
Refundable income taxes ex
Income tax receivable
Total current assets
Property and equipment, net
Deferred buy-back lease asset, net
Other assets
Total assets
Current liabilities
Accounts payable - trade
Accrued expenses and other liabilities
Accounts payable - trade
Accrued expenses and other liabilities
Deferred revenue
Deferred buy-bacl lease obligation
Operating Leases Liabilities
Deferred buy-back lease obligation
Accrued compensation
Accrued income taxes
Operating lease liabilities
Current maturities of notes payable
Customer deposits
Total current liabilities
Notes payable - less current maturities
PPP loan
Deferred tax liability
Total liabilities
Commitments and contingencies
Stockholders' equity
Preferred stock, $.01 par value; authorized 1,000,000 shares, none issued and outstanding
Common stock, $.01 par value; authorized 8,000,000 shares; 5,347,882 and 5,347,474 issued and 5,306,962 and 5,306,554 outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Treasury stock, at cost, 40,920 shares
Retained earnings
Total stockholders' equity
Total liabilities and stockholders' equity

Comments